Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000898432-25-000809·Amneal Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
Amneal Pharmaceuticals Inc
Class A Common Stock, par value $0.01 · CUSIP: 03168L105
Event date: 2025-10-03
- Filing-level shares
- 25,910,032
- Percent of class
- 8.2%
- Patel ChintuReported CIK 0001737428
Shares: 25,910,032 · Class: 8.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000898432-25-000809
- Form type
- SCHEDULE 13D/A
- Filer
- Amneal Pharmaceuticals, Inc.
- CIK
- CIK 1723128
- Filed
- Oct 07, 2025
- Reporting period
- Oct 03, 2025
- Description
- Schedule 13D beneficial ownership